IP Library Granted Patent US 12,186,423
Granted Patent B2
US 12,186,423 · App. 17/302,623 · Granted Jan 7, 2025

Brightening booster technology and brightening ampule

Inventors: Tiffany Carle (Addison, TX); Geetha Kalahasti (Addison, TX); David Gan (Addison, TX); Wanli Zhao (Addison, TX)
Assignee: MARY KAY INC.
A61K8/9789A61K8/34A61K8/345A61K8/362A61K8/365A61K8/39A61K8/44A61K8/675A61K8/73A61Q19/007A61Q19/02A61K2800/5922
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,186,423
App. No.
17/302,623
Granted
Jan 7, 2025
Kind
B2
Abstract

The present invention relates generally to methods of use and compositions useful to reduce the appearance of uneven skin tone, reduce the appearance of skin discoloration, reduce visible skin discoloration, improve the appearance of uneven skin tone, improve the brightness of skin, prevent the production of discoloration, limit uneven skin tone from appearing on skin, increase moisture levels, attract water, brighten, renew the skin, increase skin radiance, soothe the skin, increase skin smoothness, hydrate skin, smooth skin, brighten skin, reduce signs of aging in skin, and/or increase the efficacy of cosmetic products to brighten, renew the skin, increase skin radiance, sooth the skin, increase skin smoothness, hydrate skin, smooth skin, brighten skin, and/or reduce signs of aging in skin. The composition includes a combination of niacinamide, vegetable amino acids, and ferulic acid.

Claims (29)

1. A method of inhibiting melanogenesis in skin of a person in need thereof, the method comprising topically applying to skin of the person a composition comprising 0.1 to 3% by weight of niacinamide, 0.1 to 3% by weight of navy bean extract, and 0.01 to 1% by weight of ferulic acid, and the composition does not include a pyridoxine compound, and wherein topical application of the composition inhibits melanogenesis and does not provide protection from infrared radiation and/or visible light.

2. The method of claim 1 , wherein a second skin care composition is applied to the skin before application of the composition to the skin or the composition is combined with a second skin care composition prior to application to the skin.

3. The method of claim 1 , wherein the composition comprises the said amount of ferulic acid to inhibit tyrosinase and/or the melanosome transfer pathway to reduce free radical formation and/or reduce synthesis of discoloration factors.

4. The method of claim 1 , wherein the composition comprises the said amount of niacinamide to inhibit the melanosome transfer pathway to reduce production of discoloration factors and/or reduce integration of discoloration factors into skin cells.

5. The method of claim 2 , wherein the second skin care composition affects a brightening effect on skin.

6. The method of claim 2 , wherein the second skin care composition does not affect a brightening effect on skin.

7. The method of claim 1 , wherein the composition further comprises one or more of: a humectant, a skin conditioning agent, a viscosity controlling agent, a preservative, and/or a pH adjuster.

8. The method of claim 1 , wherein the composition further comprises an effective amount of one or more of: water, PEG-8, glycerin, ethoxydiglycol, and/or xanthan gum to moisturize, condition, and/or enhance a skin product's brightening effect.

9. The method of claim 8 , wherein the composition comprises:

1 to 95% by weight water;

1 to 25% by weight PEG-8;

0.1 to 15% by weight glycerin;

0.1 to 15% by weight ethoxydiglycol; and/or

0.01 to 5% by weight xanthan gum.

10. The method of claim 1 , wherein the composition further comprises one or more of: propanediol, phenoxyethanol, and/or sodium citrate.

11. The method of claim 10 , wherein the composition comprises:

0.1 to 15% by weight propanediol;

0.01 to 5% by weight phenoxyethanol; and/or

0.01 to 5% by weight sodium citrate.

12. The method of claim 1 , wherein the composition further comprises 35 to 85% by weight of water.

13. The method of claim 1 , wherein the composition further comprises 1 to 10% by weight of glycerin.

14. The method of claim 1 , wherein the composition does not provide protection from visible light.

15. The method of claim 1 , wherein the composition further comprises Opuntia tuna extract.

16. A method of enhancing the activity of a skin care composition, the method comprising combining an enhancing composition and the skin care composition,

wherein the enhancing composition comprises 0.1 to 3% by weight of niacinamide, 0.1 to 3% by weight of navy bean extract, and 0.01 to 1% by weight of ferulic acid,

wherein the enhancing composition and the skin care composition do not include a pyridoxine compound, and the enhancing composition does not provide protection from infrared radiation and/or visible light, and

wherein combining the enhancing composition and the skin composition increases or promotes an ability of the skin care composition to inhibit melanogenesis.

17. The method of claim 1 , wherein the composition comprises 2 to 3% by weight of niacinamide, 0.3 to 2% by weight of navy bean extract, and 0.1 to 0.4% by weight of ferulic acid.

18. The method of claim 1 , wherein inhibiting melanogenesis comprises reducing skin discoloration, reducing or improving uneven skin tone, improving skin brightness, or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2021
From: CARLE, TIFFANY; KALAHASTI, GEETHA; GAN, DAVID; ZHAO, WANLI
To: MARY KAY INC.
Reel/Frame 057165/0498 →
Continuity (2)
Provisional Application 63023184 · May 11, 2020
Related Publication 20210346275A1 · Nov 11, 2021
References Cited (28)
US 7332152B2 · Sanzgiri et al. · 2008 [cited by applicant]
US 8063005B2 · Kalidindi · 2011 [cited by applicant]
US 8293218B2 · Rosa et al. · 2012 [cited by applicant]
US 9072919B2 · Pan et al. · 2015 [cited by applicant]
US 9107853B2 · Pan et al. · 2015 [cited by applicant]
US 9974721B2 · Meyer et al. · 2018 [cited by applicant]
US 10137072B2 · Pan et al. · 2018 [cited by applicant]
US 10149808B2 · Pan et al. · 2018 [cited by applicant]
US 20050100517A1 · Sanzgiri · 2005 [cited by examiner]
US 20140363386A1 · Manfredini et al. · 2014 [cited by applicant]
US 20160067163A1 · Meyer et al. · 2016 [cited by applicant]
US 20180116936A1 · Pan et al. · 2018 [cited by applicant]
US 20180169166A1 · Kim et al. · 2018 [cited by applicant]
US 20190159989A1 · Deng et al. · 2019 [cited by applicant]
US 20190167569A1 · Ozayman · 2019 [cited by applicant]
BR PI0415157B1 · 2016 [cited by examiner]
CN 104905996 · 2015 [cited by applicant]
CN 104921978 · 2015 [cited by applicant]
EP 2793848 · 2014 [cited by applicant]
WO WO0170190 · 2001 [cited by applicant]
Healthline, ([retrieved from on-line website: https://www.healthline.com/health/hyperpigmentation#types, pp. 1-5, last visit Nov. 16, 2022]). (Year: 2022). [cited by examiner]
CN104905996—EPO Google English translation. (Year: 2015). [cited by examiner]
Database GNPD [Online] MINTEL, “Enriched Serum” retrieved from URL <www.qnpd.com > database accession No. 6269799, Jan. 16, 2019. [cited by applicant]
Database GNPD [Online] MINTEL, “Moisture Balancing Cream” retrieved from URL < www.qnpd.com > database accession No. 5429201, Feb. 5, 2018. [cited by applicant]
International Search Report and Written Opinion issued in Corresponding PCT Application No. PCT/US2021/070521, dated Sep. 29, 2021. [cited by applicant]
Li et al., “Navy Bean and Rice Bran Intake Alters the Plasma Metabolome of Children at Risk for Cardiovascular Disease” [cited by applicant]
Office Action and Search Report issued in Corresponding Chinese Application No. 202110509968.7, dated Aug. 24, 2024 (English Translation provided). [cited by applicant]
Peng, Guanjie et al. [cited by applicant]